CopyMark Law Group
4.9/5
Drawing for CLAYAUTHO

USPTO serial 79356230

CLAYAUTHO

Reviewed by CopyMark Law Group

Reg. 7383292Status 700Registered
Filing date
Status date
Registration date
May 14, 2024
Examiner
LADNER, CHRISOPHER G
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CLAYAUTHO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 30, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 8, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 8, 2024FIMPFINAL DISPOSITION PROCESSED—
Aug 14, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 21, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 14, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 14, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 1, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 1, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 4, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 27, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 26, 2024GPNXNOTIFICATION PROCESSED BY IB—
Feb 7, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 7, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 7, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 7, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 16, 2024PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jan 2, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 22, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 21, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 21, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 21, 2023RFNTREFUSAL PROCESSED BY IB—
Aug 3, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 3, 2023RFRRREFUSAL PROCESSED BY MPU—
Jun 27, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 26, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2023DOCKASSIGNED TO EXAMINER—
Dec 9, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 5, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 1, 2022LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Dec 1, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance